<p>The present invention discloses a method of treating or preventing a Streptococcus pneumoniae infection wherein the Streptococcus pneumoniae infection occurs in an environment where the free concentration of Zn2+ and/or Mn2+ is sufficiently low to upregulate the expression of at least one PhtX protein (for example PhtD) in the Streptococcus pneumoniae; comprising the step of administering a pharmaceutically effective amount of the PhtX protein to a human patient.</p>
申请公布号
CA2791946(A1)
申请公布日期
2011.09.15
申请号
CA20112791946
申请日期
2011.03.08
申请人
GLAXOSMITH KLINE BIOLOGICALS S.A.
发明人
DENOEL, PHILIPPE;HERMAND, PHILIPPE VINCENT;LABBE, STEVE;POOLMAN, JAN;RIOUX, STEPHANE